• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

睾丸精原细胞瘤:放射治疗后的治疗结果及失败模式

Seminoma of the testis: results of treatment and patterns of failure after radiation therapy.

作者信息

Thomas G M, Rider W D, Dembo A J, Cummings B J, Gospodarowicz M, Hawkins N V, Herman J G, Keen C W

出版信息

Int J Radiat Oncol Biol Phys. 1982 Feb;8(2):165-74. doi: 10.1016/0360-3016(82)90509-0.

DOI:10.1016/0360-3016(82)90509-0
PMID:7085374
Abstract

Four hundred and forty-four patients with the histological diagnosis of pure seminoma were treated at The Princess Margaret Hospital between 1958 and 1976. Using the Walter Reed Hospital staging classification, 338 patients (76.1%) were Stage I, 86 (19.4%) were Stage II, and 20 (4.7%) were Stage III. The 5 year actuarial survival rate (5 yr Sa) for all stages was 87%, and for Stages I, II and III: 94%, 74% and 32% respectively. In Stage II the 5-year Sa was significantly worse when palpable abdominal disease was present (62%, vs 87% when it was absent, p less than .02). Prophylactic mediastinal irradiation was not used for patients with Stage II disease. None of 40 Stage II patients without palpable abdominal disease recurred in the non-irradiated mediastinum. Ten of 46 Stage II patients with palpable abdominal disease recurred in the mediastinum; 7 of the 10 were cured with mediastinal irradiation at the time of relapse. Prophylactic mediastinal irradiation appears unnecessary in Stage II patients. The Stage III category includes a subgroup of patients who were curable with radiation therapy:L 5/6 with supradiaphragmatic nodal disease without palpable abdominal or visceral disease were cured. Exploration of new treatment methods appears indicated for the salvage of patients recurring in sites other than the mediastinum or supraclavicular fossa and for patients presenting with visceral disease.

摘要

1958年至1976年间,444例经组织学诊断为纯精原细胞瘤的患者在玛格丽特公主医院接受了治疗。采用沃尔特·里德医院分期分类法,338例患者(76.1%)为I期,86例(19.4%)为II期,20例(4.7%)为III期。所有分期的5年精算生存率(5 yr Sa)为87%,I期、II期和III期分别为94%、74%和32%。在II期,当可触及腹部病变时,5年生存率明显较差(62%,而无腹部病变时为87%,p<0.02)。II期疾病患者未采用预防性纵隔照射。40例无腹部可触及病变的II期患者中,无1例在未照射的纵隔复发。46例有腹部可触及病变的II期患者中有10例在纵隔复发;其中7例在复发时经纵隔照射治愈。II期患者似乎无需预防性纵隔照射。III期包括一组可通过放射治疗治愈的患者:L 5/6有膈上淋巴结病变且无腹部或内脏可触及病变的患者被治愈。对于在纵隔或锁骨上窝以外部位复发的患者以及有内脏疾病的患者,探索新的治疗方法似乎是必要的。

相似文献

1
Seminoma of the testis: results of treatment and patterns of failure after radiation therapy.睾丸精原细胞瘤:放射治疗后的治疗结果及失败模式
Int J Radiat Oncol Biol Phys. 1982 Feb;8(2):165-74. doi: 10.1016/0360-3016(82)90509-0.
2
Seminoma of the testis: a 22-year experience with radiation therapy.睾丸精原细胞瘤:22年放射治疗经验
Int J Radiat Oncol Biol Phys. 1985 Oct;11(10):1769-75. doi: 10.1016/0360-3016(85)90030-6.
3
Radiation therapy of pure seminoma of the testicle.
J Med Assoc Ga. 1990 Mar;79(3):181-3.
4
Is mediastinal irradiation necessary for stage I testicular seminoma?I期睾丸精原细胞瘤是否需要纵隔放疗?
J Surg Oncol. 1984 Apr;25(4):250-1. doi: 10.1002/jso.2930250406.
5
Modern radiotherapy results with bulky stages II and III seminoma.现代放疗在II期和III期巨大型精原细胞瘤中的治疗结果。
J Urol. 1990 Sep;144(3):685-9. doi: 10.1016/s0022-5347(17)39555-1.
6
[Role of radiotherapy in the treatment of seminoma of the testis].
Radiol Med. 1991 Sep;82(3):334-8.
7
Radiation therapy of seminoma of the testis.睾丸精原细胞瘤的放射治疗。
J Surg Oncol. 1985 Jan;28(1):1-3. doi: 10.1002/jso.2930280102.
8
[Radiotherapy of seminoma: small-volume irradiation at the stage pT1N0M0--prophylactic irradiation of the mediastinum].
Strahlenther Onkol. 1986 Dec;162(12):735-41.
9
Testicular seminoma: effectiveness of primary radiation therapy.
South Med J. 1987 Feb;80(2):201-4. doi: 10.1097/00007611-198702000-00015.
10
Testicular seminoma: analysis of treatment results and failures.睾丸精原细胞瘤:治疗结果与失败情况分析
Int J Radiat Oncol Biol Phys. 1986 Mar;12(3):353-8. doi: 10.1016/0360-3016(86)90350-0.

引用本文的文献

1
The diagnostic yield of fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography in recurrent testicular seminoma.氟-18氟脱氧葡萄糖正电子发射断层扫描-计算机断层扫描在复发性睾丸精原细胞瘤中的诊断效能
Urol Ann. 2016 Oct-Dec;8(4):496-499. doi: 10.4103/0974-7796.192090.
2
Treatment of advanced seminoma with cyclophosphamide, vincristine and carboplatin on an outpatient basis.门诊使用环磷酰胺、长春新碱和卡铂治疗晚期精原细胞瘤。
Br J Cancer. 1996 Sep;74(6):947-50. doi: 10.1038/bjc.1996.462.
3
Testicular seminoma: 20-year experience at the Northern Israel Oncology Center (1968-1988).
Int Urol Nephrol. 1994;26(4):461-9. doi: 10.1007/BF02768019.
4
Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874. EORTC GU Group.顺铂、长春新碱与异环磷酰胺联合化疗治疗转移性精原细胞瘤:欧洲癌症研究与治疗组织(EORTC)30874试验结果。EORTC泌尿生殖系统肿瘤协作组
Br J Cancer. 1995 Mar;71(3):619-24. doi: 10.1038/bjc.1995.121.
5
Advanced seminoma: treatment with cis-platinum-based combination chemotherapy or carboplatin (JM8).晚期精原细胞瘤:采用顺铂联合化疗或卡铂治疗(JM8)。
Br J Cancer. 1985 Jul;52(1):7-13. doi: 10.1038/bjc.1985.141.
6
The management of testicular seminoma: Edinburgh 1970-1981.睾丸精原细胞瘤的治疗:爱丁堡,1970 - 1981年
Br J Cancer. 1987 Apr;55(4):443-8. doi: 10.1038/bjc.1987.87.
7
Update in cancer chemotherapy: genitourinary tract cancer, Part 4: Testicular cancer.癌症化疗进展:泌尿生殖系统癌症,第4部分:睾丸癌。
J Natl Med Assoc. 1988 Apr;80(4):425-35.
8
Mortality in patients with testicular cancer.睾丸癌患者的死亡率。
Br Med J (Clin Res Ed). 1986 Mar 29;292(6524):901. doi: 10.1136/bmj.292.6524.901-a.
9
Curability of third ventricular region tumours. A multidisciplinary approach to evaluate the places of operative, radiation and chemotherapy.
Acta Neurochir (Wien). 1989;98(1-2):19-24. doi: 10.1007/BF01407171.
10
Chemotherapy of metastatic seminoma.转移性精原细胞瘤的化疗
Br J Cancer. 1985 Apr;51(4):467-72. doi: 10.1038/bjc.1985.67.